September 25, 2015
City of New York, et al. v. Abbott Laboratories, et al.
Average Wholesale Price (“AWP”) serves as a benchmark from which state Medicaid programs reimburse pharmacies for providing pharmaceuticals to Medicaid participants. The plaintiffs allege that pharmaceutical manufacturers routinely inflated the AWPs they reported to trade publications, causing the plaintiffs to overpay for Medicaid reimbursements.
Econ One was retained by counsel for the plaintiffs in City of New York, et al. v. Abbott Laboratories, et al. Econ One expert Jeffrey Leitzinger submitted multiple expert reports analyzing the Medicaid reimbursements made by the plaintiffs. Dr. Leitzinger also provided deposition testimony. The case settled prior to trial.